PIK3CA and chronic myelogenous leukemia, BCR-ABL1 positive: During progression of CML, several signaling pathways become activated in cancer cells, however, many converge into principal downstream signaling networks, such as, the PI3K and STAT pathways which are very critical in the evolution of drug-resistant CML.